Analog television systems are rapidly being replaced by digital television systems accross the world. Turkey is not an exception to this development since the government has recently decided to shut-down analog television transmission across the country by 2016. In this context, subject matter of this study is the adoption of digital television in Turkey. And the study&rsquo / s main aim is to understand and explain the economical and political rationale behind the conversion to digital television. In the switch process to digital television, digital television has been presented as a new &ldquo / revolutionary&rdquo / technology which is primarily to enhance the television &ldquo / service&rdquo / for viewers by the champions of the process and the governments. However, this study takes a critical position against this argument and argues that the adoption of digital television is primarily shaped by the commercial stakes of private broadcasting organisations and administrative concerns of governments. In this respect, this thesis argues that even though the digital television has technical superiorities to analog television systems which facilitates the introduction more television channels with higher audio-visual quality, the adoption of digital television does not include any project to improve the quality of television content, the equal access to information in the society and thus citizenship in a democratic society. Quite the contrary, since digital television facilitates and improves pay television implementations, digital television seems to deteriorate the imbalance in the society in accessing the information. It is therefore necessary to put &ldquo / reserve&rdquo / on the expectations from digital television. To articulate this thesis, different national contexts including USA and Britain as leading countries and Turkey in digital television conversion process are dealt with in the study. Firstly, the American and Britain experience of digital television which does not exclude the European context are examined in terms of common developments as well as the pecularities of the countries concerning to switch to digital television. Lastly, in the framework given above, the developments as to the digital television in Turkey are examined in detail. As well as the assessments about recent developments as to the issue, interviews carried out with the representatives of the broadcasting industry and regulatory authorities are also included in the analysis. Hence, this study should be considered as a descriptive research which aims to contribute the academic efforts to develop a conceptual framework to the digital television debate in Turkey.

In United States and other developed economies, technology transfer is a very important issue. The success of technology transfer is related with industrial upgrade and the development of economics. It is also a key mechanism to efficiently use those research achievements of universities to commercialize and transfer those valuable technologies. There are many research institutions and agricultural technology research organizations in Taiwan. Because the government support the research organizations continuously, Taiwan¡¦s universities has many valuable research results. In the age valuable Intellectual Pattern Right, the formal intellectual property rights, including patents, technological transfer, and the technological licensing, are still little in Taiwan¡¦s universities. So this research¡¦s main idea is to find a ideal model of the technology licensing office based on the processes of technology commercialization and u.s universities¡¦ experiences. The method utilized for collecting data in this thesis was to interview with the experts, researchers and governmental officers to gather the primary information. The other was to gather the secondary information, including research papers, books, theses, and magazines from the On-line databases and libraries. This thesis analyzes the technology transfer system and management policies based on five different points of view, i.e., the initial stage of technology development, the incubation of new technology, the resource attainment , demo of new technology, and the promotion. The important result observed from the thesis is that the degree of commercialization of the research results is not enough. In addition, Taiwan¡¦s technology transfer center just provide limited function. So, there are only few patents and royalties from technological transfer and low ratio of successful commercialization in Taiwan¡¦s universities. Meanwhile, most technology transfer in Taiwan happened through informal channel. So, the effects on technology transfer centers are not so strong. Three suggestions are drawn from the thesis: (1). The IPR conception of researchers is not enough. Researchers should be encouraged to apply pattens and IPR to improve the quality and quantity of Taiwan¡¦s intellectual property. (2). The technology transfer center should clarify the value of the research results and play the role of connection between industry and research institutions. (3). The regulations of IPR in Taiwan should be quickly updated to catch up the fast advancement of technologies.. Furthermore, the infrastructures of agriculture-related IPR management system should be built-up well. keyword¡Gtechnology transfer center¡Buniversity technology transfer¡BIntellectual Patten Right¡Btechnology licensing¡Btechnology commercialization.

<p>Research Questions: Following questions will be looked at from a management perspective in the researched elite hockey clubs: (1) How has the commercialization affected the areas of responsibility? In regards to areas of responsibility: (a) How has the commercialization affected the decision making? (b) How has the commercialization affected the information and communication? (c) How has the commercialization affected the motivation? In addition, we need to find out the overall structure of the clubs and the managers’ view on commercialization in non-profit organizations. Therefore we need to add two more research questions: (2) In what respect is the organizational structure experienced in a different way today? and (3) How has the commercialization changed Swedish hockey clubs?</p><p>Purpose: The purpose of this thesis is to create an understanding about how managers in Swedish elite hockey clubs experience the assumed adjustments in organizational structure and areas of responsibility when turning into more commercial organizations.</p><p>Method: With an interpretive hermeneutic approach used in the sense of a qualitative study, we explain how the managers of five hockey clubs within Elitserien experience the adjustments when turning into more commercial organizations. The qualitative study consisted of a number of personal and phone interviews in order to collect the empirical data.</p><p>Results: The main implication of the commercialization of Swedish hockey is that it has created conflicts in the daily operations, caused by the contradictions between commercial and non-profit activities. In addition, the organizational structure has in general become more professional with an increasing amount of distinct areas of responsibility.</p>

This thesis focuses on the commercialization of Chinese medicine in the post-Mao era, from 1977 to 2014. It looks at its social and environmental impact on local rural areas.

Within the field of microfinance, there has been an ongoing debate about whether microfinance institutions should be commercialized. One side argues that a business that very much can earn profits at the same time as it helps the poor, is not justified to receive charity, but should be run with the risks and benefits of any other profit-seeking business. The other side argues that the outreach to the ones who most need microfinance, is severely hampered if firms are profit-seeking; arguing that they only target the individuals who allow them to make profits.   This study is a case study based on India, one of the world’s largest nations, and home to millions of people living below the poverty line[1]. Microfinance is widespread in India, and with one of the researchers speaking Hindi, India became our choice of case study. A grounded theory methodology is applied in order for us to learn as much as possible about the context of microfinance in India. Within the context, we look for the mission and the impact of the various institutions. Analysis is done through the constant comparison method; with comparisons within and between different organizations. Each organization is individually analyzed to find recurring themes, always being open to the emergence of new themes. Then, the organizations are compared with others of the same legal form, and finally with all other forms of organizations.   Several different kinds of institutions are identified, working directly or indirectly with providing small loans to low-income individuals. These institutions include banks, local area banks, section 25 companies, NGOs, and cooperative societies. Each one of the institutions has, by law, different areas of restriction and the study finds that the missions of the various organizations can be linked to their legal form; the mission indicating which form they currently operate under or which legal form they are striving to achieve. The major difference between the various legal forms is their methods of accumulating finances, and how they manage their revenue. Although banks actually earn profits, they have not yet been fully commercialized, as they are restricted from attracting mainstream international capital.   The conclusions indicate that in India, microfinance has not reached the point where it has been fully commercialized, but rather the passion for their work and visions of the founders very much guide the work of the various organizations. This can be seen in the missions that guide the organizations and the services provided to fulfill the mission. Commercialization is however, far from a non-issue. If legislation regarding IPOs is changed, the level of commercialization and competitive scene for microfinance in India could change dramatically. [1] Can be measured in different ways, but used here symbolically, indicating a very low amount; discussed in more detail in the paper.

This study examines the relationship between an inventor’s motives and creativity, invention commercialization, and collaboration pattern. Special emphasis is placed on the educational background of inventors when examining the effect of inventor motive on invention commercialization. The data are based in a unique survey of patent inventors in the United States, and archival data. The GT/RIETI 2007 Inventor Survey includes information on commercialization for patented inventions and measures of inventor motives. Archival data based on Lai et al. (2011) was the basis for the collection of creativity measures based on U.S. patent technology subclasses. The results indicate that inventors’ motives differentiate the outcome of innovative activities. We found a firm motive has a positive effect on creating new combinations, commercialization of patents, and collaboration with coworkers. The results also suggest that the recognition motive negatively affects the creation of new combinations, and that there is no effect on the commercialization of the patent. As for collaboration pattern, the results show that individual differences in motives are associated with different patterns in collaboration. For example, task-oriented inventors are less likely to collaborate with others outside of the firm entity, whereas inventors with recognition motives are more likely to have a larger collaborative network with other professionals in the same field. This paper suggests that policy-makers should consider individual heterogeneity in innovative performance, knowledge creation, and patterns of collaboration. Based on the findings, future research and policy implications are discussed.

Despite the global progress made in improving health of people and increasing the life expectancy, Sub-Saharan Africa continues to be plagued by many health problems. Commercialization of health products from Sub-Saharan Africa presents opportunities to solve some of these health problems as well as generate economic returns. This thesis explored science based health product commercialization in sub-Saharan Africa through three studies. The objective was to identify opportunities and challenges facing health product commercialization in Sub-Saharan Africa. A qualitative case study approach was used and data collected using interviews. The first study involved looking at science based health product commercialization at a national level. Rwanda was chosen for this study. Thirty eight key informants selected from various institutions that form the health innovation system in Rwanda were interviewed. The results of the study show that opportunities exist in Rwanda for health product commercialization mainly because of the strong political will to support health innovation. However the main challenge is that there are no linkages between the actors involved in health innovation in Rwanda. The second study looked at health innovation at the level of a research institution. The Kenya Medical Research Institute (KEMRI) was studied where eight key informants were interviewed. The results show that KEMRI faced many challenges in its attempt at health product development, including shifting markets, lack of infrastructure, inadequate financing, and weak human capital with respect to innovation. However, it overcame them through diversification, partnerships and changes in culture. The third study looked at health technologies that are being developed in sub-Saharan Africa but have stagnated in laboratories. Thirty nine key informants were interviewed. A total of 25 technologies were identified, the majority being traditional plant medicines; other technologies identified included diagnostic tests and medical devices. Many of these technologies require further validation. Other key challenges to commercialization of these technologies that were identified included a lack of innovative culture amoung scientists and policy makers and lack of proof of concept funds including venture capital. Overall, this thesis identified opportunities for science based health commercialization in Africa, and also provides recommendations on how to overcome major challenges.

Despite the global progress made in improving health of people and increasing the life expectancy, Sub-Saharan Africa continues to be plagued by many health problems. Commercialization of health products from Sub-Saharan Africa presents opportunities to solve some of these health problems as well as generate economic returns. This thesis explored science based health product commercialization in sub-Saharan Africa through three studies. The objective was to identify opportunities and challenges facing health product commercialization in Sub-Saharan Africa. A qualitative case study approach was used and data collected using interviews. The first study involved looking at science based health product commercialization at a national level. Rwanda was chosen for this study. Thirty eight key informants selected from various institutions that form the health innovation system in Rwanda were interviewed. The results of the study show that opportunities exist in Rwanda for health product commercialization mainly because of the strong political will to support health innovation. However the main challenge is that there are no linkages between the actors involved in health innovation in Rwanda. The second study looked at health innovation at the level of a research institution. The Kenya Medical Research Institute (KEMRI) was studied where eight key informants were interviewed. The results show that KEMRI faced many challenges in its attempt at health product development, including shifting markets, lack of infrastructure, inadequate financing, and weak human capital with respect to innovation. However, it overcame them through diversification, partnerships and changes in culture. The third study looked at health technologies that are being developed in sub-Saharan Africa but have stagnated in laboratories. Thirty nine key informants were interviewed. A total of 25 technologies were identified, the majority being traditional plant medicines; other technologies identified included diagnostic tests and medical devices. Many of these technologies require further validation. Other key challenges to commercialization of these technologies that were identified included a lack of innovative culture amoung scientists and policy makers and lack of proof of concept funds including venture capital. Overall, this thesis identified opportunities for science based health commercialization in Africa, and also provides recommendations on how to overcome major challenges.

Magistro tezių darbo tikslas: Atskleisti polifarmijos priežastis vėlyvosios modernybės visuomenėje. Nuolat besikeičianti visuomenė lemia pokyčius visuose socialinio gyvenimo lygmenyse. Kintanti visuomenė iškelia naujus iššūkius tiek socialiniam veikėjui, tiek ir pačiai visuomenei. Pokyčiai palietė ir sveikatos priežiūros sistemos sektorių. Besiplėtojančios biotechnologijos įgalino mediciną įveikti infekcines ligas, bet tuo pačiu iškelia ir naujų iššūkių. Augantis lėtinių ligų spektras skatina ne tik milžiniškų lėšų skyrimą medikamentų nuo šių ligų kūrimui, bet ir prevenciją. Šiam tikslui pasitelkiama ne tik farmacijos pramonė, bet ir žiniasklaida, kuri yra vienas iš pagrindinių medikamentų vartojimą skatinančių veiksnių. Matydami besišypsančius, gerai nusiteikusius medikamentų reklamos aktorius, daroma prielaida, kad ir socialiniam veikėjui, turinčiam ar bent manančiam turint tam tikrą negalavimą, reklamuojamas medikamentas padės išspręsti esamas ar menamas sveikatos problemas. Beck (2006) kalbėdamas apie rizikos visuomenę, pačią riziką įvardijo kaip subjektyvią, o rizikos galimybę-objektyvią. Rizikų socialinio veikėjo sveikatai kyla nuolat. Ji yra įtakojama daugeliu veiksnių, dėl to jos pamatavimas išlieka subjektyviame lygmenyje. Juk pvz. Gydytojai tiksliai negali nusakyti galimus onkologinius susirgimus, kadangi jie yra veikiama daugeliu veiksnių, tai ir gyvenimo stiliaus ypatumai, aplinka, genetika ir pan. O pačias galimybes medikai apibrėžia kaip rizikos faktorius ir... [toliau žr. visą tekstą] / The goal of master thesis is intended to identify the polipharmacy factors in the late modern society. The continuously shifting society is the cause for changes in all the ways society operates. The agency of shifting society boosts new challenges for social actor as well as for society itself. These social changes have also affected healthcare system. Thanks to new biotechnologies that are being developed, medicine can overcome infectious diseases; however, the development of biotechnologies also poses new challenges. The increasing spectrum of chronic diseases not only prompts large funding of the development of pharmaceuticals to cure these diseases, but also the disease prevention in society. To achieve this goal, pharmaceutical industry and mass media, which is one of the biggest motivators for the increase in pharmaceutical consumerism, are employed. By viewing the smiling and well-spirited actors in mass media and pharmaceutical advertising, a social actor presumes that the pharmaceutical could also in a particular case be beneficial to him/her. While discussing risk society, Beck (2006) defines risk as subjective and the possibility of risk as objective. A social actor constantly experiences health risks. Health risk depends on various factors; therefore, risk measurement remains subjective. As for example, the doctors are not able to give the precise diagnosis of probable oncological disorders, since they depend on many factors such as lifestyle, environment... [to full text]

No description available.